The Bioresources team is committed to the reliable progression of the most effective therapeutic candidates into full preclinical development.
All queries regarding bioresources or ethics should be directed to:
We custom designs studies to screen potential new therapies for the treatment of various neurological disorders. We will help a client develop a tailored selection of the following core platforms with independent, objective clinical and preclinical interpretation:
- Imaging and analysis (Human MRI and PET-CT, 4.7T MRI, Microscopy)
- Neurological models
- Behavioural testing services
- Surgical services
- Flow cytometry
Animal efficacy models are available in house for studies of Parkinson’s disease, Alzheimer disease, Huntington’s disease, Stroke and Amylotrophic Lateral Sclerosis.
Clients are involved at every stage of a project:
- Study design and assessment selection
- Core data feedback to inform further development
- Interpretation and decision-making
The Florey Animal Ethics Committee (AEC) Terms of Reference and Procedural Guidelines can be found here [PDF].
Brain health affects all Australians. You can support our research by making a donation or a bequest.